PIN63 Vaccination Against Herpes Zoster and Post-Herpetic Neuralgia in France: A Cost-Effectiveness Analysis

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.1130
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Successful Treatment of Post Herpetic Neuralgia and Herpes Zoster (Shingles) With Homeopathic Medicines

Journal of Clinical and Investigative Dermatology
2017English

Cost-Effectiveness Assessment of Herpes Zoster Vaccination in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Pin56 - Cost-Effectiveness of Varicella and Herpes Zoster Vaccination in the Swedish Population

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

On Neuralgia Following Herpes Zoster

BMJ
1849English

Treatment of Shingles and Post-Herpetic Neuralgia

BMJ
1989English

Laser Evoked Potential: Analysis of the Methodology in Post Herpetic Neuralgia

World Journal of Neuroscience
2012English

Clinical and Psychosocial Correlates of Post-Herpetic Neuralgia

Journal of Medical Virology
VirologyInfectious Diseases
2008English

Distribution of Health Effects and Cost-Effectiveness of Varicella Vaccination Are Shaped by the Impact on Herpes Zoster

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Prm65 - Different Cost Effectiveness Models Used for Economic Evaluation in Moderate to Severe Painful Diabetic Neuropathy or Post-Herpetic Neuralgia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy